Adewoye E O, Adele B O
Afr J Med Med Sci. 2015 Sep;44(3):261-8.
Increased generation of free radicals from protein glycation has been associated with compromised integrity of erythrocytes in diabetes. Musa sapientum has been reported to possess anti-diabetic properties and this study investigated the effect of methanol extract of Musa sapientum on protein glycation and erythrocyte integrity.
Forty-two male Wistar rats (180-200g) were randomly grouped into seven: 1 (control), 2 (diabetic untreated), 3 (normal extract-treated (250 mg/kg)), 4 (normal metformin-treated (150 mg/kg)), 5 (diabetic extract-treated (250 mg/kg)), 6 (diabetic metformin-treated (150 mg/kg)), 7 (diabetic insulin-treated (1 IU/kg)). Diabetes was induced with single intraperitoneal injection of 120 mg/kg alloxan. Animals were treated for 14 days and blood (3 mls) was collected from retro-orbital plexus to determine serum fructosamine level, erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities. Glycated haemoglobin (HbA(1c)) level was estimated using a conversion formula. Animals were sacrificed thereafter by cervical dislocation and pancreatic tissues were excised and stained with haematoxylin and eosin for histological study. Statistical significance at P < 0.05 was analyzed by one-way ANOVA and Newman-Keuls' post-hoc test.
Diabetic rats treated with extract, metformin and insulin had significant reduction in serum fructosamine level by 62.64%, 74.63% and 56.05% respectively while HbA(1c) level reduced by 45.06%, 50.62% and 40.57% respectively. Activities of erythrocyte SOD and GPx were increased in the extract-treated group. Histological studies showed regeneration of islet cells in the diabetic extract-treated rat which was comparable to normal.
The extract inhibited protein glycation, regenerated the islet cells and improved erythrocyte antioxidant status in diabetic rats.
蛋白质糖基化产生的自由基增加与糖尿病患者红细胞完整性受损有关。据报道,香蕉具有抗糖尿病特性,本研究调查了香蕉甲醇提取物对蛋白质糖基化和红细胞完整性的影响。
将42只雄性Wistar大鼠(180 - 200克)随机分为七组:1组(对照组)、2组(未治疗糖尿病组)、3组(正常提取物治疗组(250毫克/千克))、4组(正常二甲双胍治疗组(150毫克/千克))、5组(糖尿病提取物治疗组(250毫克/千克))、6组(糖尿病二甲双胍治疗组(150毫克/千克))、7组(糖尿病胰岛素治疗组(1国际单位/千克))。通过单次腹腔注射120毫克/千克四氧嘧啶诱导糖尿病。动物治疗14天,从眶后丛收集3毫升血液,以测定血清果糖胺水平、红细胞超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)活性。使用换算公式估算糖化血红蛋白(HbA1c)水平。此后通过颈椎脱臼处死动物,切除胰腺组织并用苏木精和伊红染色进行组织学研究。采用单因素方差分析和Newman - Keuls事后检验分析P < 0.05时的统计学意义。
用提取物、二甲双胍和胰岛素治疗的糖尿病大鼠血清果糖胺水平分别显著降低62.64%、74.63%和56.05%,而HbA1c水平分别降低45.0 6%、50.62%和40.57%。提取物治疗组红细胞SOD和GPx活性增加。组织学研究显示,糖尿病提取物治疗大鼠的胰岛细胞再生,与正常情况相当。
该提取物可抑制糖尿病大鼠的蛋白质糖基化,使胰岛细胞再生并改善红细胞抗氧化状态。